Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
xconomy.com » Xconomy Venture Capital Feed - Oct 17, 2008
Roundup, Life Sciences, Stocks Rebecca Zacks wrote: There was not one venture financing among Boston-area life sciences firms that I could find this week, but plenty of news nonetheless. —Luke took a look at …
Also tagged: drugs, people, roundup, boston, glaxosmithkline, deals, startups, pfizer, stocks, pharma, life sciences, new leaf venture partners, biogen idec, boston scientific, greylock partners, synta pharmaceuticals, james tobin, boston blog main, flagship ventures, national blog main, targanta therapeutics, alantos pharmaceuticals, tvm capital, skyline ventures, westfield capital management, concert pharmaceuticals, three arch partners, adage capital management, sr one, brookside capital partners fund, qvt fund, mediphase venture partners, alexandria real estate equities, craig mello, rxi pharmaceuticals, brigham and 38 women s hospital, roger tung, john abele, charles river laboratories international, pete nicholas, mark benedyk, surface logix, keith dionne
xconomy.com » Xconomy Life Sciences Feed - Oct 16, 2008
Roundup, Life Sciences, Stocks Rebecca Zacks wrote: There was not one venture financing among Boston-area life sciences firms that I could find this week, but plenty of news nonetheless. —Luke took a look at …
Also tagged: drugs, people, roundup, boston, glaxosmithkline, deals, startups, pfizer, stocks, pharma, life sciences, new leaf venture partners, biogen idec, boston scientific, greylock partners, synta pharmaceuticals, james tobin, boston blog main, flagship ventures, national blog main, targanta therapeutics, alantos pharmaceuticals, tvm capital, skyline ventures, westfield capital management, concert pharmaceuticals, three arch partners, adage capital management, sr one, brookside capital partners fund, qvt fund, mediphase venture partners, alexandria real estate equities, craig mello, rxi pharmaceuticals, brigham and 38 women s hospital, roger tung, john abele, charles river laboratories international, pete nicholas, mark benedyk, surface logix, keith dionne
 |
Provasculon, a Biogen-backed Startup, Testing Regenerative Medicine on Heartsxconomy.com » Xconomy Boston - Oct 10, 2008 Biotech, Heart Disease, Biogen Idec Luke Timmerman wrote: Provasculon is tackling one of the bigger ideas in regenerative medicine—how to stimulate growth of new blood vessels after they’ve been damaged by a heart … Also tagged: biotech, boston, heart disease, stem cells, life sciences, genzyme, biogen idec, massachusetts general hospital, richard lee, boston blog main, national blog main, naomi aoki, brigham and 38 women s hospital, bioheart, partners healthcare, vincent segers, sdf 1, anthony sandrasagra |
xconomy.com » Xconomy Life Sciences Feed - Oct 9, 2008
Biotech, Heart Disease, Biogen Idec Luke Timmerman wrote: Provasculon is tackling one of the bigger ideas in regenerative medicine—how to stimulate growth of new blood vessels after they’ve been damaged by a heart …
Also tagged: biotech, boston, heart disease, stem cells, life sciences, genzyme, biogen idec, massachusetts general hospital, richard lee, boston blog main, national blog main, naomi aoki, brigham and 38 women s hospital, bioheart, partners healthcare, vincent segers, sdf 1, anthony sandrasagra